Effects of Different Neoadjuvant Chemotherapy Regimens on Immune Indicators and Tumor Microenvironment in HER-2-positive Breast Cancer Patients
Background Breast cancer is a common clinical malignant tumor, which seriously affects the health of women. Although the current targeted therapy system for breast cancer is well established, the difference in clinical efficacy between double-target therapy and single-target therapy remains unclear...
Main Author: | PEI Bei, CHENG Lin, XU Lingyun |
---|---|
Format: | Article |
Language: | zho |
Published: |
Chinese General Practice Publishing House Co., Ltd
2023-09-01
|
Series: | Zhongguo quanke yixue |
Subjects: | |
Online Access: | https://www.chinagp.net/fileup/1007-9572/PDF/1687830841493-24201144.pdf |
Similar Items
-
Clinical efficacy of neoadjuvant FAC chemotherapy in locally advanced breast cancer patients
by: Ždrale Zdravko, et al.
Published: (2003-01-01) -
Real-world data on neoadjuvant chemotherapy with dual-anti HER2 therapy in HER2 positive breast cancer
by: Zheng-Jun Yang, et al.
Published: (2024-01-01) -
The role of chemotherapy in the management of resectable colorectal cancer
by: Radosavljević Davorin Z., et al.
Published: (2003-01-01) -
Research advances on chemotherapy and targeted therapy of pediatric - type low - grade glioma
by: GE Jing-jing, et al.
Published: (2024-09-01) -
Combination chemotherapy for metastatic colorectal cancer
by: Koehne Claus-Henning
Published: (2003-01-01)